SCHEMBL25348271

SCHEMBL25348271

NC(=O)c1ccc(OC(=O)O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 17/20 0.66
PARP15 Q460N3 4/20 0.64
PARP4 Q9UKK3 2/20 0.64
PARP14 Q460N5 2/20 0.64
ALDH1A1 P00352 1/20 0.64
KMT2A Q03164 1/20 0.64
PARP16 Q8N5Y8 1/20 0.64
PARP11 Q9NR21 1/20 0.64
PARP2 Q9UGN5 3/20 0.59
PARP1 P09874 2/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
HGFAC Q04756 1/20 0.53
POLB P06746 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
TSHR P16473 1/20 0.52
CYP2C19 P33261 1/20 0.52
RECQL P46063 1/20 0.52
BLM P54132 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9391321 0.84 PARP10 (0.63) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL15259341 0.84 PARP10 (0.67) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL28095695 0.84 PARP10 (0.67) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL686286 0.83 ELANE (0.65) ALDH1A1KMT2APOLBHSD17B10
SCHEMBL465132 0.83 LMNA (0.52) ALDH1A1KMT2APOLBMAPTHSD17B10
SCHEMBL13135334 0.81 HSD17B10 (0.67) PARP10PARP15KMT2ACA1CA2
SCHEMBL28670578 0.80 LMNA (0.50) ALDH1A1KMT2APOLBMAPTHSD17B10
SCHEMBL23486305 0.79 PARP10 (1.00) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL27615624 0.78 KIF11 (0.59) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL3137816 0.78 PARP10 (1.00) PARP10PARP15PARP4PARP14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234913-A1 METHOD FOR PREPARING PRIMARY AMIDE COMPOUNDS FROM SECONDARY OR TERTIARY AMIDES INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234913-A1 METHOD FOR PREPARING PRIMARY AMIDE COMPOUNDS FROM SECONDARY OR TERTIARY AMIDES CA3, NAAA, ATL3 PARP10 2269/4885PARP15 2512/4885PARP4 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.